AURINIA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Buyers {that a} Class Motion Lawsuit Has Been Filed In opposition to Aurinia Prescribed drugs, Inc. and Encourages Buyers to Contact the Agency – Lawyer Month-to-month

NEW YORK–(BUSINESS WIRE)–#AUPH–Bragar Eagel & Squire, P.C., a nationally acknowledged stockholder rights legislation agency, reminds buyers {that a} class motion lawsuit has been filed towards Aurinia Prescribed drugs, Inc. (“Aurinia” or the “Firm”) (NASDAQ: AUPH) in the USA District Courtroom for the Japanese District of New York on behalf of all individuals and entities who bought or in any other case acquired Aurinia securities between Could 7, 2021 and February 25, 2022, each dates inclusive (the “Class Interval”). Buyers have till June 14, 2022 to use to the Courtroom to be appointed as lead plaintiff within the lawsuit.

Click on right here to take part within the motion.

Aurinia is a biopharmaceutical firm that develops and commercializes therapies to deal with varied ailments with unmet medical want in Japan and the Individuals’s Republic of China (“China”). The Firm’s solely product is LUPKYNIS, which it gives for the remedy of grownup sufferers with lively lupus nephritis.

All through the Class Interval, Defendants made materially false and deceptive statements concerning the Firm’s enterprise, operations, and compliance insurance policies. Particularly, Defendants made false and/or deceptive statements and/or didn't disclose that: (i) Aurinia was experiencing declining revenues; (ii) Aurinia’s 2022 gross sales outlook for LUPKYNIS would fall nicely wanting expectations; (iii) accordingly, the Firm had considerably overstated LUPKYNIS’s business prospects; (iv) in consequence, the Firm had overstated its monetary place and/or prospects for 2022; and (v) in consequence, the Firm’s public statements have been materially false and deceptive in any respect related occasions.

On February 28, 2022, Aurinia issued a press launch saying its monetary outcomes for the quarter and full yr ended December 31, 2021. Amongst different objects, Aurinia reported a year-over-year income decline and introduced a lower-than-expected gross sales outlook for 2022.

On this information, Aurinia’s frequent share value fell $3.94 per share, or 24.26%, to shut at $12.30 per share on February 28, 2022.

Because of Defendants’ wrongful acts and omissions, and the precipitous decline available in the market worth of the Firm’s securities, Plaintiff and different Class members have suffered vital losses and damages.

For those who bought or in any other case acquired Aurinia shares and suffered a loss, are a long-term stockholder, have data, want to be taught extra about these claims, or have any questions regarding this announcement or your rights or pursuits with respect to those issues, please contact Brandon Walker or Alexandra Raymond by e-mail at, phone at (212) 355-4648, or by filling out this contact kind. There is no such thing as a price or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally acknowledged legislation agency with workplaces in New York and California. The agency represents particular person and institutional buyers in business, securities, by-product, and different advanced litigation in state and federal courts throughout the nation. For extra details about the agency, please go to Lawyer promoting. Prior outcomes don't assure comparable outcomes.


Bragar Eagel & Squire, P.C.

Brandon Walker, Esq.

Alexandra B. Raymond, Esq.

(212) 355-4648

Leave a Reply

Your email address will not be published.

Go up